Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity

Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity

US Patent 6946492 · Granted Sep 20, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Support bearing of a vibration damper in a wheel suspension of a vehicle2021
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
Amino alcohol-substituted arylthienopyrimidinones, process for their preparation2014
Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, ob2014
Substituted tetrahydronaphthalenes, method for the production thereof, and use t2014
Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and2014
Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation 2014
Use of IκB-kinase inhibitors in pain therapy2014
Indole derivatives or benzimidazole derivatives for modulating IkB kinase2014
Substituted tetrahydronaphthalenes, process for the preparation thereof and the 2013